Serum amyloid A facilitates expansion of CD4+ T cell and CD19+ B cell subsets implicated in the severity of myasthenia gravis patients
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Neurochemistry"
DOI: 10.1111/jnc.16047
Abstract: Serum amyloid A (SAA) is a clinically useful inflammatory marker involved in the pathogenesis of autoimmune diseases. This study aimed to explore the SAA levels in a cohort of patients with myasthenia gravis (MG) in… read more here.
Keywords: cell subsets; saa; cell; cd19 cell ... See more keywords
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Immunology Research"
DOI: 10.1158/2326-6066.cir-21-0853
Abstract: Engineered T lymphocytes secreting anti–CD19 T-cell engagers (STAb-T19) prevent the down-modulation of CD19 and result in rapid, efficient elimination of cancer cells by recruiting endogenous T cells, thus preventing CD19-positive relapses associated with CD19-targeting CAR… read more here.
Keywords: cd19 cell; cell; lymphocytes secreting; secreting anti ... See more keywords
CD19 (+) B Cell Combined with Prognostic Nutritional Index Predicts the Clinical Outcomes of Patients with Gastric Cancer Who Underwent Surgery
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15092531
Abstract: Simple Summary Gastric cancer has a high degree of malignancy, and even with comprehensive surgical treatment, there is still a high probability of recurrence and metastasis. Finding accurate predictive biomarkers can screen high-risk patients and… read more here.
Keywords: underwent surgery; cd19 cell; cell; gastric cancer ... See more keywords